Population Health Research Institute, Department of Medicine, Hamilton, ON, Canada.
Population Health Research Institute, Department of Medicine, Hamilton, ON, Canada.
Lancet Respir Med. 2013 Oct;1(8):599-609. doi: 10.1016/S2213-2600(13)70164-4. Epub 2013 Sep 10.
Despite the rising burden of chronic respiratory diseases, global data for lung function are not available. We investigated global variation in lung function in healthy populations by region to establish whether regional factors contribute to lung function.
In an international, community-based prospective study, we enrolled individuals from communities in 17 countries between Jan 1, 2005, and Dec 31, 2009 (except for in Karnataka, India, where enrolment began on Jan 1, 2003). Trained local staff obtained data from participants with interview-based questionnaires, measured weight and height, and recorded forced expiratory volume in 1 s (FEV₁) and forced vital capacity (FVC). We analysed data from participants 130-190 cm tall and aged 34-80 years who had a 5 pack-year smoking history or less, who were not affected by specified disorders and were not pregnant, and for whom we had at least two FEV₁ and FVC measurements that did not vary by more than 200 mL. We divided the countries into seven socioeconomic and geographical regions: south Asia (India, Bangladesh, and Pakistan), east Asia (China), southeast Asia (Malaysia), sub-Saharan Africa (South Africa and Zimbabwe), South America (Argentina, Brazil, Colombia, and Chile), the Middle East (Iran, United Arab Emirates, and Turkey), and North America or Europe (Canada, Sweden, and Poland). Data were analysed with non-linear regression to model height, age, sex, and region.
153,996 individuals were enrolled from 628 communities. Data from 38,517 asymptomatic, healthy non-smokers (25,614 women; 12,903 men) were analysed. For all regions, lung function increased with height non-linearly, decreased with age, and was proportionately higher in men than women. The quantitative effect of height, age, and sex on lung function differed by region. Compared with North America or Europe, FEV1 adjusted for height, age, and sex was 31·3% (95% CI 30·8-31·8%) lower in south Asia, 24·2% (23·5-24·9%) lower in southeast Asia, 12·8% (12·4-13·4%) lower in east Asia, 20·9% (19·9-22·0%) lower in sub-Saharan Africa, 5·7% (5·1-6·4%) lower in South America, and 11·2% (10·6-11·8%) lower in the Middle East. We recorded similar but larger differences in FVC. The differences were not accounted for by variation in weight, urban versus rural location, and education level between regions.
Lung function differs substantially between regions of the world. These large differences are not explained by factors investigated in this study; the contribution of socioeconomic, genetic, and environmental factors and their interactions with lung function and lung health need further clarification.
Full funding sources listed at end of the paper (see Acknowledgments).
尽管慢性呼吸道疾病的负担不断增加,但全球仍缺乏有关肺功能的数据。我们通过地区研究了健康人群的肺功能全球差异,以确定地区因素是否对肺功能有影响。
在这项国际、以社区为基础的前瞻性研究中,我们于 2005 年 1 月 1 日至 2009 年 12 月 31 日期间在 17 个国家的社区中招募了参与者(印度的卡纳塔克邦除外,该邦的招募工作于 2003 年 1 月 1 日开始)。经过培训的当地工作人员通过基于访谈的调查问卷收集参与者的数据,测量体重和身高,并记录用力呼气量 1 秒率(FEV₁)和用力肺活量(FVC)。我们分析了身高在 130-190cm 之间、年龄在 34-80 岁之间、吸烟史不超过 5 包年、未受特定疾病影响且未怀孕的参与者的数据,并且我们至少有两次 FEV₁ 和 FVC 测量值,这两次测量值的差异不超过 200mL。我们将这些国家分为七个社会经济和地理区域:南亚(印度、孟加拉国和巴基斯坦)、东亚(中国)、东南亚(马来西亚)、撒哈拉以南非洲(南非和津巴布韦)、南美洲(阿根廷、巴西、哥伦比亚和智利)、中东(伊朗、阿拉伯联合酋长国和土耳其)和北美或欧洲(加拿大、瑞典和波兰)。我们使用非线性回归分析数据,以建立身高、年龄、性别和地区模型。
从 628 个社区共招募了 153996 名参与者。分析了来自 38517 名无症状、健康、不吸烟的个体(25614 名女性;12903 名男性)的数据。对于所有地区,肺功能随身高呈非线性增加,随年龄下降,并且男性比女性的比例更高。身高、年龄和性别对肺功能的定量影响因地区而异。与北美或欧洲相比,南亚地区 FEV1 按身高、年龄和性别校正后低 31.3%(95%CI 30.8-31.8%),东南亚地区低 24.2%(23.5-24.9%),东亚地区低 12.8%(12.4-13.4%),撒哈拉以南非洲地区低 20.9%(19.9-22.0%),南美洲地区低 5.7%(5.1-6.4%),中东地区低 11.2%(10.6-11.8%)。我们记录到了类似但更大的 FVC 差异。这些差异无法用地区间体重、城乡位置和教育水平的差异来解释。
肺功能在世界不同地区存在显著差异。这些巨大差异无法用本研究中调查的因素来解释;社会经济、遗传和环境因素及其与肺功能和肺部健康的相互作用的影响需要进一步阐明。
全文列出了资金来源(见致谢)。